gefitinib - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
CIPLA GEFITINIB gefitinib 250 mg tablet blister pack AUST R: 318433Active ingredients:
gefitinib
Dosage form:
Tablet, film coated
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
08 Aug 2024
to
01 Jun 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Alternative product is available
|
IRESSA gefitinib 250 mg tablet blister pack AUST R: 90010Active ingredients:
gefitinib
Dosage form:
Tablet, film coated
Sponsor:
AstraZeneca Pty Ltd
Phone:
1800805342
|
Deletion from market:
01 Jul 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
|